Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ELI LILLY & Co Director's Dealing 2010

Dec 17, 2010

29745_dirs_2010-12-17_216ef124-ad61-4b78-be3c-00926873bdad.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LILLY ELI & CO (LLY)
CIK: 0000059478
Period of Report: 2010-12-16

Reporting Person: Carmine Bryce D. (EVP and Pres, Lilly Bio-Meds)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2010-12-06 Common Stock G 45 $0.00 Disposed 63295 Direct
2010-12-07 Common Stock G 60 $0.00 Disposed 63235 Direct
2010-12-09 Common Stock G 105 $0.00 Disposed 63130 Direct
2010-12-16 Common Stock S 3100 $35.10 Disposed 60030 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 6085 Indirect

Footnotes

F1: The transaction reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 1, 2010.